跳至主要内容
临床试验/NCT03238482
NCT03238482已完成1 期

Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler 50/250 µg/Dose Products and Seretide Diskus 50/250 µg/Dose in Healthy Subjects

Orion Corporation, Orion Pharma1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2017年8月16日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
64
试验地点
1
主要终点
Peak plasma concentration (Cmax) of salmeterol

研究概览

简要总结

The purpose of this study is to compare absorption of salmeterol and fluticasone from Salmeterol/fluticasone Easyhaler test products to the commercially available product Seretide Diskus

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Seretide Diskus

Active Comparator

salmeterol-fluticasone 2 inhalations as a single dose

干预措施: salmeterol-fluticasone (Drug)

Salmeterol/fluticasone Easyhaler, E

Experimental

salmeterol-fluticasone 2 inhalations as a single dose

干预措施: salmeterol-fluticasone (Drug)

Salmeterol/fluticasone Easyhaler, F

Experimental

salmeterol-fluticasone 2 inhalations as a single dose

干预措施: salmeterol-fluticasone (Drug)

Salmeterol/fluticasone Easyhaler, G

Experimental

salmeterol-fluticasone 2 inhalations as a single dose

干预措施: salmeterol-fluticasone (Drug)

结局指标

主要结局

Peak plasma concentration (Cmax) of salmeterol

时间窗: between 0-34 hours after dosing

Cmax of salmeterol

Truncated area under the plasma concentration versus time curve (AUC) of salmeterol

时间窗: 0-30 minutes after dosing

AUC from time zero to 30 min after study treatment administration

Peak plasma concentration (Cmax) of fluticasone propionate

时间窗: between 0-34 hours after dosing

Cmax of fluticasone propionate

Area under the plasma concentration versus time curve (AUC) of fluticasone propionate

时间窗: 0-34 hours after dosing

AUC from time zero to the last sample with the quantifiable concentration

Area under the plasma concentration versus time curve (AUC) of salmeterol

时间窗: 0-34 hours after dosing

AUC from time zero to the last sample with the quantifiable concentration

次要结局

  • Area under the plasma concentration versus time curve (AUC) of salmeterol(0-34 hours after dosing and extrapolation)
  • The terminal elimination half-life (t1/2) of fluticasone propionate(0-34 hours after dosing)
  • Area under the plasma concentration versus time curve (AUC) of fluticasone propionate(0-34 hours after dosing and extrapolation)
  • The time to reach the maximum concentration (tmax) of salmeterol(0-34 hours after dosing)
  • The time to reach the maximum concentration (tmax) of fluticasone propionate(0-34 hours after dosing)
  • The terminal elimination half-life (t1/2) of salmeterol(0-34 hours after dosing)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验